82zijkjl.200x156x1

Global leaders

The GLOBAL LEADERS trial is an Investigator-Sponsored Study (ISS) in which 16,000 “all-comer” patients will be enrolled in approximately 132 sites ...


Read more >>

 152brwo4

Syntax II

SYNTAX II is a European multicenter single-arm study investigating the effectiveness of a new generation stent - incorporating pressure wire assessment (ischemia-driven revascularisation) and ...


Read more >>

 151rjjbzq

Absorb stemi: The Trofi II Study

ABSORB STEMI: the TROFI II Study is a European multicenter randomized study to assess the safety and performance of ABSORB bioresorbable scaffold in the treatment of ...


Read more >>

 63sge5sg

SYNTAX III Revolution

SYNTAX III Revolution: A randomized study to evaluate the feasibility of Heart-Team clinical decision making regarding the optimal (surgical or percutaneous based) revascularization ...


Read more >>

 syntax-3-revolution

Dessolve III

Dessolve III is a prospective, single-blind (patient), randomized, controlled, multicenter study. Approximately 17 sites in Europe will participate. The enrollment required ...


Read more >>

 dessolve-III

GALILEO 4D

The GALILEO 4D trial is a randomized comparison of a rivaroxaban-based strategy with an antiplatelet-based strategy following successful TAVR for the prevention of leaflet thickening ...


Read more >>

 galilei-logo-157x201

Talent

TALENT is a prospective, randomized, 1:1 balanced, controlled, single-blind, multi-center study comparing clinical outcomes at 12 months between SUPRAFLEX and XIENCE in a “Real world, all comers” patient population ...


Read more >>

 Talent-Logo-201x157-1

MASTER DAPT

MASTER DAPT is an Investigator-initiated, multi-center, randomized clinical trial in HBR patients after
PCI with Ultimaster bioresorbable polymer coated sirolimus-eluting stent implantation.


Read more >>

 master-dapt-logo-final-cmyk.340x275x1.202x163